Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.
Julie Burek net worth and biography

Julie Burek Biography and Net Worth

Julie Burek is Vice President-Finance for Voyager Therapeutics, Inc.

In the past she was Senior Manager-Finance at Biogen, Inc.

Ms. Burek received an undergraduate degree from Bentley University and an MBA from Northeastern University.

How do I contact Julie Burek?

The corporate mailing address for Ms. Burek and other Voyager Therapeutics executives is 75 SIDNEY STREET, CAMBRIDGE MA, 02139. Voyager Therapeutics can also be reached via phone at (857) 259-5340 and via email at [email protected] Learn More on Julie Burek's contact information.

Has Julie Burek been buying or selling shares of Voyager Therapeutics?

Julie Burek has not been actively trading shares of Voyager Therapeutics within the last three months. Most recently, Julie Burek sold 265 shares of the business's stock in a transaction on Wednesday, January 12th. The shares were sold at an average price of $3.06, for a transaction totalling $810.90. Learn More on Julie Burek's trading history.

Are insiders buying or selling shares of Voyager Therapeutics?

In the last year, Voyager Therapeutics insiders bought shares 2 times. They purchased a total of 477,400 shares worth more than $2,663,552.00. In the last year, insiders at the sold shares 16 times. They sold a total of 1,434,526 shares worth more than $10,390,578.63. The most recent insider tranaction occured on January, 25th when Major Shareholder Rock Ventures Iii L.P. Third sold 50,000 shares worth more than $461,000.00. Insiders at Voyager Therapeutics own 22.0% of the company. Learn More about insider trades at Voyager Therapeutics.

Information on this page was last updated on 1/25/2023.

Julie Burek Insider Trading History at Voyager Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/12/2022Sell265$3.06$810.90View SEC Filing Icon  
1/3/2022Sell3,063$2.83$8,668.29View SEC Filing Icon  
See Full Table

Julie Burek Buying and Selling Activity at Voyager Therapeutics

This chart shows Julie Burek's buying and selling at Voyager Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Voyager Therapeutics Company Overview

Voyager Therapeutics logo
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.
Read More

Today's Range

Now: $9.01
Low: $8.90
High: $9.22

50 Day Range

MA: $6.87
Low: $5.36
High: $10.78

2 Week Range

Now: $9.01
Low: $2.76
High: $10.81

Volume

251,100 shs

Average Volume

664,044 shs

Market Capitalization

$347.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
click here now to get all the chilling details.